描述
A comprehensive summary of curcumin trial endpoints in ulcerative colitis is presented, integrating clinical, endoscopic, histological, and biomarker outcomes across the included studies.
Figure 41
Source Paper
The Use of Curcumin as a Complementary Therapy in Ulcerative Colitis: A Systematic Review of Randomized Controlled Clinical Trials.Cite This Figure
![Figure 41: A comprehensive summary of curcumin trial endpoints in ulcerative colitis is presented, integrating clinical, endoscopic, histological, and biomarker outcomes across the included studies.]() > Source: Mariana Roque Coelho et al. "The Use of Curcumin as a Complementary Therapy in Ulcerative Colitis: A Systemat." *Nutrients*, 2020. PMID: [32751776](https://pubmed.ncbi.nlm.nih.gov/32751776/)
<figure> <img src="" alt="A comprehensive summary of curcumin trial endpoints in ulcerative colitis is presented, integrating clinical, endoscopic, histological, and biomarker outcomes across the included studies." /> <figcaption>Figure 41. A comprehensive summary of curcumin trial endpoints in ulcerative colitis is presented, integrating clinical, endoscopic, histological, and biomarker outcomes across the included studies.<br> Source: Mariana Roque Coelho et al. "The Use of Curcumin as a Complementary Therapy in Ulcerative Colitis: A Systemat." <em>Nutrients</em>, 2020. PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/32751776/">32751776</a></figcaption> </figure>